LINC02144

Across TCGA pan-cancer cohorts, LINC02144 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC02144 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC02144 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02144 expression acts as an unfavorable survival marker, although some lineages such as GBM and SKCM show a favorable association.

LUAD, SARC, and HNSC are the cancer types where LINC02144 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.181	0.391	<.001	141	view →
SARC	OS	Tertile	All	0.118	0.531	<.001	48	view →
HNSC	DFS	Tertile	III,IV	0.179	0.519	.004	45	view →
ACC	OS	Tertile	All	0.229	0.675	.001	39	view →
LIHC	DFS	Tertile	All	0.170	0.565	<.001	39	view →
CESC	OS	Tertile	III,IV	0.156	0.657	.027	36	view →
BRCA	OS	Tertile	IV	0.233	0.755	.038	36	view →
UVM	DFS	Tertile	All	0.079	0.746	<.001	27	view →
PCPG	DFS	Tertile	All	0.648	0.909	<.001	18	view →
GBM	OS	Tertile	All	0.485	0.249	.011	12	view →
ESCA	DFS	Tertile	IV	0.216	0.542	.021	12	view →
THCA	OS	Tertile	III,IV	0.889	0.988	.008	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LINC02144–LUAD (OS)

Open the LUAD breakdown →